Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical 3D/4D cumulative proton dose assessment methods for thoracic tumours with large motion
Visser, S., Korevaar, E. W., Muijs, C. T., Wijsman, R., Langendijk, J. A., Pisciotta, P., Guterres Marmitt, G., Ribeiro, C. O. & Both, S., May-2023, In: Radiotherapy and Oncology. 182, 8 p., 109575.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Safety and tolerability of stereotactic radiotherapy combined with durvalumab with or without tremelimumab in advanced non-small cell lung cancer, the phase I SICI trial
Kievit, H., Muntinghe-Wagenaar, M. B., Hijmering-Kappelle, L. B. M., Hiddinga, B. I., Ubbels, J. F., Wijsman, R., Slingers, G., de Vries, R., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J. & Hiltermann, T. J. N., Apr-2023, In: Lung Cancer. 178, p. 96-102 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Survival prediction for stage I-IIIA non-small cell lung cancer using deep learning
Zheng, S., Guo, J., Langendijk, J. A., Both, S., N J Veldhuis, R., Oudkerk, M., van Ooijen, P. M. A., Wijsman, R. & Sijtsema, N. M., Mar-2023, In: Radiotherapy and Oncology. 180, 18 p., 109483.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile14 Downloads (Pure) -
The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation
Dieleman, E., van der Woude, L., van Os, R., van Bockel, L., Coremans, I., van Es, C., De Jaeger, K., Knol, H. P., Kolff, W., Koppe, F., Pomp, J., Reymen, B., Schinagl, D., Spoelstra, F., Tissing-Tan, C., van der Voort van Zyp, N., van der Wel, A., Wijsman, R., Dielwart, M., Wiegman, E., & 2 others, Mar-2023, In: Clinical lung cancer. 24, 2, p. 130-136 7 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)1 Downloads (Pure) -
A phase 1 study in patients with advanced non-small cell lung cancer treated with stereotactic radiotherapy to the primary tumor combined with durvalumab and tremelimumab
Kievit, H., Muntinghe-Wagenaar, M. B., Ubbels, F., Wijsman, R., Hijmering-Kappelle, L., Hiddinga, B., Groen, H. J. M., Kerstjens, H. A. M., van der Wekken, A. J. & Hiltermann, T. J. N., 1-Jun-2022, In: Journal of Clinical Oncology. 40, 16_suppl, p. e21121-e21121 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
-
Feasibility of dose escalation for NSCLC using IMPT
Arno Hessels (Speaker), Sabine Visser (Contributor), Stefan Both (Contributor), Erik Korevaar (Contributor), Johannes Albertus Langendijk (Contributor) & Robin Wijsman (Contributor)
29-Jun-2022 → 1-Jul-2022Activity: Talk and presentation › Academic presentation › Academic
-
Introduction of IMPT for (N)SCLC patients: NTCP model based selection of patients and first results
Robin Wijsman (Speaker)
28-Aug-2021Activity: Talk and presentation › Professional or public presentation › Professional
-
Protonen therapie voor longkanker
Robin Wijsman (Speaker)
10-Jun-2021Activity: Talk and presentation › Professional or public presentation › Professional
-
Chemoradiatie met protonen bij stadium III NSCLC
Robin Wijsman (Speaker)
28-Sept-2021Activity: Talk and presentation › Professional or public presentation › Professional
-
Welke patiënten kan ik verwijzen voor protonentherapie?
Robin Wijsman (Speaker)
1-Sept-2020Activity: Talk and presentation › Academic presentation › Academic